

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 8.88928364 |
| 2 | white fat cell differentiation (GO:0050872) | 8.79702491 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 8.62251783 |
| 4 | brown fat cell differentiation (GO:0050873) | 8.16076002 |
| 5 | neutral lipid catabolic process (GO:0046461) | 7.94732077 |
| 6 | acylglycerol catabolic process (GO:0046464) | 7.94732077 |
| 7 | valine metabolic process (GO:0006573) | 7.78527292 |
| 8 | biotin metabolic process (GO:0006768) | 7.38124320 |
| 9 | response to peptidoglycan (GO:0032494) | 7.26733669 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.87981017 |
| 11 | defense response to fungus (GO:0050832) | 6.61575376 |
| 12 | triglyceride biosynthetic process (GO:0019432) | 6.41567238 |
| 13 | detection of bacterium (GO:0016045) | 6.15016836 |
| 14 | detection of other organism (GO:0098543) | 6.14100915 |
| 15 | neutral lipid biosynthetic process (GO:0046460) | 6.10983973 |
| 16 | acylglycerol biosynthetic process (GO:0046463) | 6.10983973 |
| 17 | lipid particle organization (GO:0034389) | 6.10000771 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.06411694 |
| 19 | glycerolipid catabolic process (GO:0046503) | 5.96668438 |
| 20 | regulation of cholesterol storage (GO:0010885) | 5.90368397 |
| 21 | leukocyte aggregation (GO:0070486) | 5.85746363 |
| 22 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.84906990 |
| 23 | cellular extravasation (GO:0045123) | 5.58516748 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 5.41263482 |
| 25 | response to fungus (GO:0009620) | 5.40777431 |
| 26 | innate immune response in mucosa (GO:0002227) | 5.31571671 |
| 27 | positive regulation of fatty acid oxidation (GO:0046321) | 5.20727941 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.19542779 |
| 29 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.16277932 |
| 30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.12005153 |
| 31 | lipid storage (GO:0019915) | 5.11897840 |
| 32 | neutrophil activation (GO:0042119) | 5.11573997 |
| 33 | branched-chain amino acid metabolic process (GO:0009081) | 5.02260868 |
| 34 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.00000614 |
| 35 | granulocyte activation (GO:0036230) | 4.97130231 |
| 36 | acyl-CoA biosynthetic process (GO:0071616) | 4.92970538 |
| 37 | thioester biosynthetic process (GO:0035384) | 4.92970538 |
| 38 | disruption of cells of other organism (GO:0044364) | 4.90530629 |
| 39 | killing of cells of other organism (GO:0031640) | 4.90530629 |
| 40 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.89756308 |
| 41 | triglyceride metabolic process (GO:0006641) | 4.86293543 |
| 42 | branched-chain amino acid catabolic process (GO:0009083) | 4.84231732 |
| 43 | protein heterotrimerization (GO:0070208) | 4.79547243 |
| 44 | carnitine shuttle (GO:0006853) | 4.76512919 |
| 45 | negative regulation of protein autophosphorylation (GO:0031953) | 4.75505118 |
| 46 | mucosal immune response (GO:0002385) | 4.73504783 |
| 47 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.72745402 |
| 48 | response to dietary excess (GO:0002021) | 4.65297292 |
| 49 | negative regulation of granulocyte differentiation (GO:0030853) | 4.64560467 |
| 50 | detection of external biotic stimulus (GO:0098581) | 4.64541773 |
| 51 | organ or tissue specific immune response (GO:0002251) | 4.64423262 |
| 52 | antibacterial humoral response (GO:0019731) | 4.58529365 |
| 53 | fatty acid beta-oxidation (GO:0006635) | 4.57779395 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 4.56710339 |
| 55 | acylglycerol metabolic process (GO:0006639) | 4.56089887 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 4.55921482 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.51559537 |
| 58 | neutral lipid metabolic process (GO:0006638) | 4.49807730 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.47529858 |
| 60 | response to host immune response (GO:0052572) | 4.47529858 |
| 61 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.45899497 |
| 62 | antimicrobial humoral response (GO:0019730) | 4.44098555 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.41835350 |
| 64 | coenzyme A biosynthetic process (GO:0015937) | 4.36990610 |
| 65 | positive regulation of glomerulus development (GO:0090193) | 4.32738212 |
| 66 | respiratory burst (GO:0045730) | 4.31763317 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.31674880 |
| 68 | fatty acid homeostasis (GO:0055089) | 4.30848940 |
| 69 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.30094188 |
| 70 | complement activation, alternative pathway (GO:0006957) | 4.29448890 |
| 71 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.29364771 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 4.29203941 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 4.22743763 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.22743763 |
| 75 | pentose-phosphate shunt (GO:0006098) | 4.22135462 |
| 76 | detection of biotic stimulus (GO:0009595) | 4.20928590 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.20864102 |
| 78 | cellular response to lithium ion (GO:0071285) | 4.20563878 |
| 79 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.18696700 |
| 80 | negative regulation of lipid storage (GO:0010888) | 4.18135197 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 4.17411868 |
| 82 | NADPH regeneration (GO:0006740) | 4.17280699 |
| 83 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.15490880 |
| 84 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.15490880 |
| 85 | negative regulation of macrophage differentiation (GO:0045650) | 4.15146072 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.12360236 |
| 87 | fatty acid oxidation (GO:0019395) | 4.09915886 |
| 88 | ovulation from ovarian follicle (GO:0001542) | 4.09004079 |
| 89 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.07872704 |
| 90 | negative regulation of interleukin-8 production (GO:0032717) | 4.06151102 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 4.03377443 |
| 92 | lipid oxidation (GO:0034440) | 4.02531845 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.01228117 |
| 94 | response to host (GO:0075136) | 4.01228117 |
| 95 | response to host defenses (GO:0052200) | 4.01228117 |
| 96 | negative regulation of metanephros development (GO:0072217) | 4.00171413 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99926436 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99926436 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 3.99926436 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99926436 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 3.99926436 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99926436 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 3.98944541 |
| 104 | negative regulation of growth of symbiont in host (GO:0044130) | 3.98626620 |
| 105 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.98626620 |
| 106 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.98626620 |
| 107 | regulation of growth of symbiont in host (GO:0044126) | 3.98626620 |
| 108 | acetyl-CoA metabolic process (GO:0006084) | 3.98225072 |
| 109 | immunoglobulin mediated immune response (GO:0016064) | 3.97858241 |
| 110 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.97294361 |
| 111 | cellular response to epinephrine stimulus (GO:0071872) | 3.95726622 |
| 112 | regulation of mast cell activation (GO:0033003) | 3.95536418 |
| 113 | alpha-linolenic acid metabolic process (GO:0036109) | 3.91987504 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.91156008 |
| 115 | carnitine transmembrane transport (GO:1902603) | 3.89775895 |
| 116 | positive regulation of glucose import (GO:0046326) | 3.86101284 |
| 117 | growth hormone receptor signaling pathway (GO:0060396) | 3.85545620 |
| 118 | negative regulation of gluconeogenesis (GO:0045721) | 3.85473795 |
| 119 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.84630130 |
| 120 | L-serine transport (GO:0015825) | 3.84275039 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 3.84194330 |
| 122 | positive regulation of cholesterol efflux (GO:0010875) | 3.83971364 |
| 123 | neutrophil chemotaxis (GO:0030593) | 3.81905369 |
| 124 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.80118506 |
| 125 | positive regulation of sterol transport (GO:0032373) | 3.76332382 |
| 126 | positive regulation of cholesterol transport (GO:0032376) | 3.76332382 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.74813475 |
| 128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.73970902 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72584458 |
| 130 | neutrophil migration (GO:1990266) | 3.72443653 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 3.72326062 |
| 132 | response to muramyl dipeptide (GO:0032495) | 3.72096964 |
| 133 | regulation of fatty acid oxidation (GO:0046320) | 3.71415140 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 3.68167044 |
| 135 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.67795664 |
| 136 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.67313246 |
| 137 | defense response to Gram-positive bacterium (GO:0050830) | 3.64622272 |
| 138 | positive regulation of lipid storage (GO:0010884) | 3.63686288 |
| 139 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.63393212 |
| 140 | negative regulation of interleukin-6 production (GO:0032715) | 3.61343372 |
| 141 | superoxide anion generation (GO:0042554) | 3.60896343 |
| 142 | adaptation of signaling pathway (GO:0023058) | 3.59352917 |
| 143 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.57777811 |
| 144 | amino-acid betaine transport (GO:0015838) | 3.56525624 |
| 145 | carnitine transport (GO:0015879) | 3.56525624 |
| 146 | diacylglycerol metabolic process (GO:0046339) | 3.56044335 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54273160 |
| 148 | negative regulation of cell killing (GO:0031342) | 3.54273160 |
| 149 | regulation of regulated secretory pathway (GO:1903305) | 3.51282291 |
| 150 | oxaloacetate metabolic process (GO:0006107) | 3.50435689 |
| 151 | regulation of triglyceride metabolic process (GO:0090207) | 3.49906079 |
| 152 | phagosome maturation (GO:0090382) | 3.48546969 |
| 153 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.48139331 |
| 154 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47323392 |
| 155 | leukocyte degranulation (GO:0043299) | 3.46898464 |
| 156 | glycerol metabolic process (GO:0006071) | 3.46571117 |
| 157 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.45542964 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 3.45425292 |
| 159 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.44740711 |
| 160 | neutrophil mediated immunity (GO:0002446) | 3.42640628 |
| 161 | cellular response to growth hormone stimulus (GO:0071378) | 3.42230087 |
| 162 | positive regulation of leukocyte degranulation (GO:0043302) | 3.39063660 |
| 163 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.38698580 |
| 164 | regulation of lipid storage (GO:0010883) | 3.38463271 |
| 165 | coenzyme A metabolic process (GO:0015936) | 3.36363107 |
| 166 | serine transport (GO:0032329) | 3.34735308 |
| 167 | detection of molecule of bacterial origin (GO:0032490) | 3.34616264 |
| 168 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.34503244 |
| 169 | regulation of receptor binding (GO:1900120) | 3.33726518 |
| 170 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.32566596 |
| 171 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30363031 |
| 172 | positive regulation of glucose transport (GO:0010828) | 3.29490616 |
| 173 | granulocyte migration (GO:0097530) | 3.28863166 |
| 174 | mast cell activation (GO:0045576) | 3.27740103 |
| 175 | macrophage activation (GO:0042116) | 3.26606257 |
| 176 | phosphatidic acid biosynthetic process (GO:0006654) | 3.26570544 |
| 177 | phosphatidic acid metabolic process (GO:0046473) | 3.26570544 |
| 178 | granulocyte chemotaxis (GO:0071621) | 3.19768672 |
| 179 | positive regulation of regulated secretory pathway (GO:1903307) | 3.18597520 |
| 180 | microglial cell activation (GO:0001774) | 3.18272315 |
| 181 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17044366 |
| 182 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13067752 |
| 183 | cell killing (GO:0001906) | 3.12270651 |
| 184 | chronic inflammatory response (GO:0002544) | 3.08778728 |
| 185 | defense response to bacterium (GO:0042742) | 3.08066979 |
| 186 | myeloid leukocyte activation (GO:0002274) | 3.07870105 |
| 187 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04404813 |
| 188 | B cell mediated immunity (GO:0019724) | 3.01456660 |
| 189 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94606617 |
| 190 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.94210306 |
| 191 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.94108855 |
| 192 | reactive oxygen species biosynthetic process (GO:1903409) | 2.93391096 |
| 193 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92151705 |
| 194 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91978197 |
| 195 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.89955547 |
| 196 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87420071 |
| 197 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87155641 |
| 198 | response to bacterium (GO:0009617) | 2.86611704 |
| 199 | sequestering of metal ion (GO:0051238) | 2.85971487 |
| 200 | low-density lipoprotein particle clearance (GO:0034383) | 10.6146416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.79052181 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.55492368 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.85256421 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23954267 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85032606 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65826233 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.52007395 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50811980 |
| 9 | * VDR_24763502_ChIP-Seq_THP-1_Human | 3.30426947 |
| 10 | * SPI1_23547873_ChIP-Seq_NB4_Human | 3.06337486 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.99281964 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.95235563 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71486592 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64425997 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60276472 |
| 16 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.59130383 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58853953 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54656094 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.51239369 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46511374 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.45912379 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43973748 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38281407 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36588541 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.34531489 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.25922927 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25684129 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24018323 |
| 29 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.18895395 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.12335755 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 2.08836335 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08035317 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07077770 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.06919978 |
| 35 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.8256886 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.99517358 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99508469 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.97582981 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93815264 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93238903 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.90068979 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88540043 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86297574 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82708762 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.81232571 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81199921 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81151360 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.80877770 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78486904 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77208052 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76205780 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69906943 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69774311 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69212014 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.61938933 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59961171 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59868520 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59264231 |
| 59 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56727342 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55745267 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55329468 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55047186 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.54899794 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53335708 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51850575 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51312219 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50902156 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47342691 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46911548 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45986258 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45978886 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.45299933 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45258372 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43108888 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41610541 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41463751 |
| 77 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38816297 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36661212 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32992484 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28781860 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27652053 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24387984 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24072907 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24023798 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23668235 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21840062 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21840062 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21095889 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20536023 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19806037 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19678958 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19602850 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18778417 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16205125 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14780169 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14469439 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11224020 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11037542 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10272597 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09932393 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08878962 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08421315 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08150489 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08107119 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07980014 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06196582 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04315444 |
| 108 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01879985 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01826889 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01396033 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99551281 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98847960 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98657485 |
| 114 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.97282906 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94324776 |
| 116 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.92229950 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91646169 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91221133 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90130555 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89781404 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89657311 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89498830 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89115644 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88337421 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87028962 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86573163 |
| 127 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86474544 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84166789 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83372704 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83101757 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82095642 |
| 132 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80747729 |
| 133 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80747729 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80592734 |
| 135 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79881417 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78670621 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78670621 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77967066 |
| 139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77258567 |
| 140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.74872729 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74737577 |
| 142 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74503127 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73947794 |
| 144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73773074 |
| 145 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.73130425 |
| 146 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72910735 |
| 147 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67751889 |
| 148 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66700818 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65245483 |
| 150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64977484 |
| 151 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64251700 |
| 152 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64239439 |
| 153 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64179383 |
| 154 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.63367900 |
| 155 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63145676 |
| 156 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.62593768 |
| 157 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.62515908 |
| 158 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61976594 |
| 159 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61886303 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61492722 |
| 161 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.60087034 |
| 162 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.59103167 |
| 163 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.59017833 |
| 164 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.58027327 |
| 165 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57567989 |
| 166 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57151529 |
| 167 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56795619 |
| 168 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.55769681 |
| 169 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55111223 |
| 170 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.54794136 |
| 171 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.54727880 |
| 172 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.54157608 |
| 173 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.52976931 |
| 174 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52856807 |
| 175 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.52649072 |
| 176 | KDM2B_26808549_Chip-Seq_K562_Human | 0.52219344 |
| 177 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.52072422 |
| 178 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.52053593 |
| 179 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51260244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.34211436 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.63370091 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 5.19929660 |
| 4 | MP0004130_abnormal_muscle_cell | 5.16806840 |
| 5 | MP0003303_peritoneal_inflammation | 4.43943348 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 4.43677108 |
| 7 | MP0003436_decreased_susceptibility_to | 4.25746229 |
| 8 | MP0005375_adipose_tissue_phenotype | 4.10794055 |
| 9 | MP0009785_altered_susceptibility_to | 3.57424309 |
| 10 | MP0002419_abnormal_innate_immunity | 3.53840705 |
| 11 | MP0002876_abnormal_thyroid_physiology | 3.42981457 |
| 12 | MP0000013_abnormal_adipose_tissue | 3.18729533 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.17248223 |
| 14 | MP0005025_abnormal_response_to | 3.16637670 |
| 15 | MP0001835_abnormal_antigen_presentation | 3.15808481 |
| 16 | MP0002971_abnormal_brown_adipose | 3.09886530 |
| 17 | MP0006082_CNS_inflammation | 3.06340787 |
| 18 | MP0005275_abnormal_skin_tensile | 2.96723320 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.92951714 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.85117015 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.81987438 |
| 22 | MP0009115_abnormal_fat_cell | 2.78825748 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.74040042 |
| 24 | MP0000003_abnormal_adipose_tissue | 2.73558972 |
| 25 | MP0005334_abnormal_fat_pad | 2.64298787 |
| 26 | MP0005387_immune_system_phenotype | 2.53991073 |
| 27 | MP0001790_abnormal_immune_system | 2.53991073 |
| 28 | MP0000685_abnormal_immune_system | 2.41036614 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.38096412 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.35652567 |
| 31 | MP0001800_abnormal_humoral_immune | 2.34653348 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 2.34203627 |
| 33 | MP0005671_abnormal_response_to | 2.34121735 |
| 34 | MP0001661_extended_life_span | 2.33325266 |
| 35 | MP0002420_abnormal_adaptive_immunity | 2.33048991 |
| 36 | MP0002723_abnormal_immune_serum | 2.32759208 |
| 37 | MP0001819_abnormal_immune_cell | 2.30405550 |
| 38 | MP0009278_abnormal_bone_marrow | 2.29895584 |
| 39 | MP0003300_gastrointestinal_ulcer | 2.27182706 |
| 40 | MP0002970_abnormal_white_adipose | 2.22811593 |
| 41 | MP0003075_altered_response_to | 2.03097991 |
| 42 | MP0003959_abnormal_lean_body | 1.97857879 |
| 43 | MP0002405_respiratory_system_inflammati | 1.93232744 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.92588743 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.89817006 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.89817006 |
| 47 | MP0005535_abnormal_body_temperature | 1.87824647 |
| 48 | * MP0002118_abnormal_lipid_homeostasis | 1.85681563 |
| 49 | MP0003724_increased_susceptibility_to | 1.85633476 |
| 50 | MP0008260_abnormal_autophagy | 1.84117570 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.80873086 |
| 52 | MP0009764_decreased_sensitivity_to | 1.77679740 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.77399658 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.75273479 |
| 55 | MP0004272_abnormal_basement_membrane | 1.72914541 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.72580442 |
| 57 | MP0003186_abnormal_redox_activity | 1.70357207 |
| 58 | MP0004510_myositis | 1.69467850 |
| 59 | MP0000716_abnormal_immune_system | 1.67599496 |
| 60 | MP0002398_abnormal_bone_marrow | 1.63257324 |
| 61 | MP0001881_abnormal_mammary_gland | 1.61506941 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.56236220 |
| 63 | MP0005448_abnormal_energy_balance | 1.55566899 |
| 64 | MP0009840_abnormal_foam_cell | 1.54432356 |
| 65 | MP0008469_abnormal_protein_level | 1.53390878 |
| 66 | MP0004947_skin_inflammation | 1.53327510 |
| 67 | MP0001851_eye_inflammation | 1.50831494 |
| 68 | MP0005452_abnormal_adipose_tissue | 1.47447506 |
| 69 | MP0003690_abnormal_glial_cell | 1.46973975 |
| 70 | MP0003828_pulmonary_edema | 1.43457886 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.41322926 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.40411448 |
| 73 | MP0002429_abnormal_blood_cell | 1.38171669 |
| 74 | MP0002722_abnormal_immune_system | 1.35130761 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.34327428 |
| 76 | MP0005310_abnormal_salivary_gland | 1.30683154 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.30541000 |
| 78 | MP0006138_congestive_heart_failure | 1.27899302 |
| 79 | MP0005166_decreased_susceptibility_to | 1.21008931 |
| 80 | * MP0000609_abnormal_liver_physiology | 1.16903328 |
| 81 | MP0000604_amyloidosis | 1.16829097 |
| 82 | MP0002060_abnormal_skin_morphology | 1.16144402 |
| 83 | MP0002796_impaired_skin_barrier | 1.14650750 |
| 84 | * MP0002078_abnormal_glucose_homeostasis | 1.13913207 |
| 85 | MP0008004_abnormal_stomach_pH | 1.12698586 |
| 86 | MP0002254_reproductive_system_inflammat | 1.12118652 |
| 87 | MP0003763_abnormal_thymus_physiology | 1.11507962 |
| 88 | MP0005365_abnormal_bile_salt | 1.11196039 |
| 89 | MP0000343_altered_response_to | 1.10527042 |
| 90 | MP0008775_abnormal_heart_ventricle | 1.09648501 |
| 91 | MP0002166_altered_tumor_susceptibility | 1.08598850 |
| 92 | MP0005164_abnormal_response_to | 1.04171289 |
| 93 | MP0002132_abnormal_respiratory_system | 1.04118850 |
| 94 | MP0001727_abnormal_embryo_implantation | 1.03705165 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 1.03704487 |
| 96 | MP0004883_abnormal_blood_vessel | 1.03443754 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.01089984 |
| 98 | MP0000751_myopathy | 0.95096914 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.94964107 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.94378826 |
| 101 | MP0001764_abnormal_homeostasis | 0.93450693 |
| 102 | MP0005390_skeleton_phenotype | 0.92570280 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.90754287 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.89636614 |
| 105 | MP0004147_increased_porphyrin_level | 0.89390396 |
| 106 | MP0001663_abnormal_digestive_system | 0.87936310 |
| 107 | MP0003045_fibrosis | 0.86945896 |
| 108 | MP0002006_tumorigenesis | 0.86598612 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.86204774 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.85053639 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.85053639 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.84715695 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.84453330 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.83778587 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.82929546 |
| 116 | MP0003646_muscle_fatigue | 0.82248141 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.80711539 |
| 118 | MP0005451_abnormal_body_composition | 0.80114397 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.79326431 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.78914817 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78393025 |
| 122 | MP0003948_abnormal_gas_homeostasis | 0.77797109 |
| 123 | MP0003795_abnormal_bone_structure | 0.77730573 |
| 124 | MP0001756_abnormal_urination | 0.77370470 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.75925476 |
| 126 | MP0003953_abnormal_hormone_level | 0.73994767 |
| 127 | MP0001177_atelectasis | 0.73328615 |
| 128 | MP0003866_abnormal_defecation | 0.72882755 |
| 129 | MP0005165_increased_susceptibility_to | 0.72016495 |
| 130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70471180 |
| 131 | MP0002396_abnormal_hematopoietic_system | 0.69847425 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.68751363 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.68341230 |
| 134 | MP0006054_spinal_hemorrhage | 0.67380409 |
| 135 | MP0002168_other_aberrant_phenotype | 0.66666569 |
| 136 | MP0004087_abnormal_muscle_fiber | 0.66514141 |
| 137 | MP0000920_abnormal_myelination | 0.66310024 |
| 138 | MP0002277_abnormal_respiratory_mucosa | 0.65879279 |
| 139 | MP0001873_stomach_inflammation | 0.65249941 |
| 140 | MP0002139_abnormal_hepatobiliary_system | 0.64497645 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.63974949 |
| 142 | MP0006036_abnormal_mitochondrial_physio | 0.63901484 |
| 143 | MP0000490_abnormal_crypts_of | 0.63885925 |
| 144 | MP0001533_abnormal_skeleton_physiology | 0.63557771 |
| 145 | MP0005083_abnormal_biliary_tract | 0.61549327 |
| 146 | MP0002877_abnormal_melanocyte_morpholog | 0.60502859 |
| 147 | MP0000427_abnormal_hair_cycle | 0.60334781 |
| 148 | MP0001542_abnormal_bone_strength | 0.59619403 |
| 149 | MP0002133_abnormal_respiratory_system | 0.58498508 |
| 150 | MP0005388_respiratory_system_phenotype | 0.58498508 |
| 151 | MP0008961_abnormal_basal_metabolism | 0.58332475 |
| 152 | MP0000249_abnormal_blood_vessel | 0.58163451 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.58054171 |
| 154 | MP0009672_abnormal_birth_weight | 0.57986700 |
| 155 | MP0009763_increased_sensitivity_to | 0.57250600 |
| 156 | MP0003448_altered_tumor_morphology | 0.57150496 |
| 157 | MP0003453_abnormal_keratinocyte_physiol | 0.56565212 |
| 158 | MP0000858_altered_metastatic_potential | 0.56182365 |
| 159 | MP0002972_abnormal_cardiac_muscle | 0.56041111 |
| 160 | MP0001986_abnormal_taste_sensitivity | 0.55726324 |
| 161 | MP0005595_abnormal_vascular_smooth | 0.55320406 |
| 162 | MP0003091_abnormal_cell_migration | 0.55146701 |
| 163 | MP0001853_heart_inflammation | 0.54561032 |
| 164 | MP0002332_abnormal_exercise_endurance | 0.54409036 |
| 165 | MP0000230_abnormal_systemic_arterial | 0.54023064 |
| 166 | MP0005647_abnormal_sex_gland | 0.53690586 |
| 167 | MP0005058_abnormal_lysosome_morphology | 0.53378360 |
| 168 | MP0005075_abnormal_melanosome_morpholog | 0.52143632 |
| 169 | MP0002295_abnormal_pulmonary_circulatio | 0.51445309 |
| 170 | MP0008874_decreased_physiological_sensi | 0.51037225 |
| 171 | MP0000015_abnormal_ear_pigmentation | 0.49270250 |
| 172 | MP0000627_abnormal_mammary_gland | 0.47141120 |
| 173 | MP0002998_abnormal_bone_remodeling | 0.46219016 |
| 174 | MP0005332_abnormal_amino_acid | 0.45712914 |
| 175 | MP0004782_abnormal_surfactant_physiolog | 0.45180757 |
| 176 | MP0002108_abnormal_muscle_morphology | 0.44980215 |
| 177 | MP0005360_urolithiasis | 0.43388724 |
| 178 | MP0004215_abnormal_myocardial_fiber | 0.43368590 |
| 179 | MP0001958_emphysema | 0.42165569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 9.53318507 |
| 2 | Acanthosis nigricans (HP:0000956) | 7.95256903 |
| 3 | Hypertriglyceridemia (HP:0002155) | 7.12902118 |
| 4 | Recurrent abscess formation (HP:0002722) | 6.16451198 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.08665908 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.92443144 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.86889212 |
| 8 | Hyperglycinuria (HP:0003108) | 5.78788996 |
| 9 | Complement deficiency (HP:0004431) | 5.59439443 |
| 10 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.26677073 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.20205892 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.20205892 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 5.20205892 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.14489190 |
| 15 | Stomatitis (HP:0010280) | 4.75212350 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.68270762 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.68270762 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 4.66363005 |
| 19 | Long foot (HP:0001833) | 4.48949365 |
| 20 | Obstructive lung disease (HP:0006536) | 4.36590398 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 4.36590398 |
| 22 | Myositis (HP:0100614) | 4.34284954 |
| 23 | Difficulty running (HP:0009046) | 4.26826147 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.12643932 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 4.09747234 |
| 26 | Abnormality of complement system (HP:0005339) | 4.03936791 |
| 27 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.00119546 |
| 28 | Growth hormone excess (HP:0000845) | 3.96921013 |
| 29 | Insulin resistance (HP:0000855) | 3.89678252 |
| 30 | Orchitis (HP:0100796) | 3.67095219 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.65861893 |
| 32 | Recurrent skin infections (HP:0001581) | 3.63737561 |
| 33 | Disinhibition (HP:0000734) | 3.63251232 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 3.62476301 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.52107526 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.51915832 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 3.50723855 |
| 38 | Optic neuritis (HP:0100653) | 3.50723855 |
| 39 | Thyroid-stimulating hormone excess (HP:0002925) | 3.49244795 |
| 40 | Bone cyst (HP:0012062) | 3.45187805 |
| 41 | Petechiae (HP:0000967) | 3.43499770 |
| 42 | Hyperthyroidism (HP:0000836) | 3.41428561 |
| 43 | Dysostosis multiplex (HP:0000943) | 3.38399801 |
| 44 | Gingivitis (HP:0000230) | 3.37505331 |
| 45 | Epidermoid cyst (HP:0200040) | 3.37235412 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 3.36932641 |
| 47 | Subcapsular cataract (HP:0000523) | 3.36699462 |
| 48 | Multiple enchondromatosis (HP:0005701) | 3.35405031 |
| 49 | Myoglobinuria (HP:0002913) | 3.34355999 |
| 50 | Increased muscle lipid content (HP:0009058) | 3.33799068 |
| 51 | Hydroxyprolinuria (HP:0003080) | 3.33674777 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 3.33674777 |
| 53 | Increased connective tissue (HP:0009025) | 3.32091485 |
| 54 | Meningitis (HP:0001287) | 3.32064840 |
| 55 | Ankle contracture (HP:0006466) | 3.27405795 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 3.24451858 |
| 57 | Loss of speech (HP:0002371) | 3.24036534 |
| 58 | Urticaria (HP:0001025) | 3.22528529 |
| 59 | Myocardial infarction (HP:0001658) | 3.17307802 |
| 60 | Hemorrhage of the eye (HP:0011885) | 3.16363885 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11669893 |
| 62 | Prolonged bleeding time (HP:0003010) | 3.11299445 |
| 63 | Hyperpituitarism (HP:0010514) | 3.09499999 |
| 64 | Large hands (HP:0001176) | 3.05946393 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03628709 |
| 66 | Follicular hyperkeratosis (HP:0007502) | 3.03436871 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.99841189 |
| 68 | Type 1 muscle fiber predominance (HP:0003803) | 2.98689195 |
| 69 | Ketoacidosis (HP:0001993) | 2.96459401 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93969877 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93969877 |
| 72 | Pancreatitis (HP:0001733) | 2.92271850 |
| 73 | Nausea (HP:0002018) | 2.90708453 |
| 74 | Mutism (HP:0002300) | 2.89460080 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.86690748 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 2.86420287 |
| 77 | Broad metatarsal (HP:0001783) | 2.85078182 |
| 78 | Episodic fever (HP:0001954) | 2.80873561 |
| 79 | Ketosis (HP:0001946) | 2.80320019 |
| 80 | Purpura (HP:0000979) | 2.79233173 |
| 81 | Increased serum ferritin (HP:0003281) | 2.78383992 |
| 82 | Epistaxis (HP:0000421) | 2.75316162 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.74833157 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 2.74478717 |
| 85 | Increased IgE level (HP:0003212) | 2.74267599 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72733118 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.72304949 |
| 88 | Vasculitis (HP:0002633) | 2.71558017 |
| 89 | Hyperglycinemia (HP:0002154) | 2.71433986 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.69560011 |
| 91 | Hypoglycemic coma (HP:0001325) | 2.68821148 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.67847829 |
| 93 | Spinal rigidity (HP:0003306) | 2.67500848 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.67235417 |
| 95 | Accelerated skeletal maturation (HP:0005616) | 2.66633021 |
| 96 | Cellulitis (HP:0100658) | 2.64052149 |
| 97 | Hypochromic anemia (HP:0001931) | 2.61910439 |
| 98 | Hemoptysis (HP:0002105) | 2.61213830 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.58861725 |
| 100 | Encephalitis (HP:0002383) | 2.58043147 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.57992632 |
| 102 | Anorexia (HP:0002039) | 2.56437200 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56284223 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56284223 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56284223 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.55576401 |
| 107 | Autoimmune thrombocytopenia (HP:0001973) | 2.54972350 |
| 108 | Cerebral aneurysm (HP:0004944) | 2.53863292 |
| 109 | Keratoconjunctivitis (HP:0001096) | 2.53215412 |
| 110 | Skin nodule (HP:0200036) | 2.49193050 |
| 111 | Prenatal maternal abnormality (HP:0002686) | 2.49169786 |
| 112 | Recurrent viral infections (HP:0004429) | 2.47911591 |
| 113 | Toxemia of pregnancy (HP:0100603) | 2.46364226 |
| 114 | Slender build (HP:0001533) | 2.45658766 |
| 115 | Osteomyelitis (HP:0002754) | 2.45314583 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.45273770 |
| 117 | Prominent supraorbital ridges (HP:0000336) | 2.45206317 |
| 118 | Aortic dissection (HP:0002647) | 2.44336126 |
| 119 | Decreased subcutaneous fat (HP:0001002) | 2.43696736 |
| 120 | Tetraparesis (HP:0002273) | 2.42693606 |
| 121 | Hyperammonemia (HP:0001987) | 2.41424322 |
| 122 | Lipoatrophy (HP:0100578) | 2.39569413 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37939924 |
| 124 | Mucopolysacchariduria (HP:0008155) | 2.37939924 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 2.37044399 |
| 126 | Abnormal hemoglobin (HP:0011902) | 2.35580638 |
| 127 | Leukocytosis (HP:0001974) | 2.35438873 |
| 128 | Gingival bleeding (HP:0000225) | 2.33612002 |
| 129 | Upper motor neuron abnormality (HP:0002127) | 2.32743204 |
| 130 | Xanthomatosis (HP:0000991) | 2.31329349 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.31063048 |
| 132 | Facial diplegia (HP:0001349) | 2.28736376 |
| 133 | Abnormal eating behavior (HP:0100738) | 2.28644819 |
| 134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27843594 |
| 135 | Microcytic anemia (HP:0001935) | 2.27366139 |
| 136 | Polygenic inheritance (HP:0010982) | 2.24400486 |
| 137 | Chest pain (HP:0100749) | 2.23746056 |
| 138 | Pustule (HP:0200039) | 2.21538719 |
| 139 | Granulocytopenia (HP:0001913) | 2.19650508 |
| 140 | Polyphagia (HP:0002591) | 2.18709582 |
| 141 | Hypercholesterolemia (HP:0003124) | 2.18495438 |
| 142 | Axonal loss (HP:0003447) | 2.17621785 |
| 143 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.17450246 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16662396 |
| 145 | Muscle fiber splitting (HP:0003555) | 2.16024966 |
| 146 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15608921 |
| 147 | Dicarboxylic aciduria (HP:0003215) | 2.15608921 |
| 148 | Premature rupture of membranes (HP:0001788) | 2.13041701 |
| 149 | Hyperglycemia (HP:0003074) | 2.12492040 |
| 150 | Glomerulonephritis (HP:0000099) | 2.10414674 |
| 151 | Interstitial pulmonary disease (HP:0006530) | 2.08776193 |
| 152 | Polar cataract (HP:0010696) | 2.08774680 |
| 153 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07811997 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 2.07787330 |
| 155 | Polycythemia (HP:0001901) | 2.07377375 |
| 156 | Pulmonary embolism (HP:0002204) | 2.05801316 |
| 157 | Clitoromegaly (HP:0000057) | 2.04596357 |
| 158 | Hypergammaglobulinemia (HP:0010702) | 2.03784126 |
| 159 | Inflammation of the large intestine (HP:0002037) | 2.02662531 |
| 160 | Gangrene (HP:0100758) | 2.02375301 |
| 161 | Venous abnormality (HP:0002624) | 2.02020812 |
| 162 | Testicular atrophy (HP:0000029) | 2.01850872 |
| 163 | Diminished motivation (HP:0000745) | 2.01736264 |
| 164 | Aortic aneurysm (HP:0004942) | 2.01373707 |
| 165 | Right ventricular cardiomyopathy (HP:0011663) | 1.99830722 |
| 166 | Agnosia (HP:0010524) | 1.99805672 |
| 167 | Arterial thrombosis (HP:0004420) | 1.98909503 |
| 168 | Stridor (HP:0010307) | 1.98660601 |
| 169 | Hypercortisolism (HP:0001578) | 1.98590084 |
| 170 | Fibular hypoplasia (HP:0003038) | 1.94391331 |
| 171 | Apathy (HP:0000741) | 1.94200045 |
| 172 | Personality changes (HP:0000751) | 1.93390687 |
| 173 | Abnormality of the pleura (HP:0002103) | 1.93181407 |
| 174 | Polyneuropathy (HP:0001271) | 1.92963814 |
| 175 | Gastrointestinal inflammation (HP:0004386) | 1.91558454 |
| 176 | Increased IgM level (HP:0003496) | 1.91167328 |
| 177 | Amyloidosis (HP:0011034) | 1.90430664 |
| 178 | Pathologic fracture (HP:0002756) | 1.89296093 |
| 179 | Enlarged penis (HP:0000040) | 1.89088003 |
| 180 | Inappropriate behavior (HP:0000719) | 1.88792602 |
| 181 | Sepsis (HP:0100806) | 1.88698230 |
| 182 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88094609 |
| 183 | Abnormality of alanine metabolism (HP:0010916) | 1.88094609 |
| 184 | Hyperalaninemia (HP:0003348) | 1.88094609 |
| 185 | Neck muscle weakness (HP:0000467) | 1.86869093 |
| 186 | Abnormal platelet volume (HP:0011876) | 1.86754669 |
| 187 | Gonadotropin excess (HP:0000837) | 1.85990647 |
| 188 | Hyporeflexia of lower limbs (HP:0002600) | 1.85640891 |
| 189 | Colitis (HP:0002583) | 1.85413235 |
| 190 | Glucose intolerance (HP:0000833) | 1.82815673 |
| 191 | Proximal amyotrophy (HP:0007126) | 1.78582946 |
| 192 | Muscle stiffness (HP:0003552) | 1.78049716 |
| 193 | Congenital, generalized hypertrichosis (HP:0004540) | 1.75041310 |
| 194 | Hepatosplenomegaly (HP:0001433) | 1.74977900 |
| 195 | Abnormality of purine metabolism (HP:0004352) | 1.73794099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 7.46676749 |
| 2 | CAMK1G | 5.42197434 |
| 3 | TRIB3 | 5.21086432 |
| 4 | RIPK4 | 5.00969342 |
| 5 | SIK1 | 4.55085125 |
| 6 | BLK | 4.22297191 |
| 7 | BCKDK | 4.11718951 |
| 8 | PRPF4B | 3.04607295 |
| 9 | PDK4 | 2.83466436 |
| 10 | PDK3 | 2.83466436 |
| 11 | MST1R | 2.65168683 |
| 12 | LMTK2 | 2.62877871 |
| 13 | GRK6 | 2.54435647 |
| 14 | IRAK4 | 2.49289592 |
| 15 | TAOK1 | 2.46673676 |
| 16 | FES | 2.41595859 |
| 17 | RIPK1 | 2.34994302 |
| 18 | ERN1 | 2.30456311 |
| 19 | MAP4K1 | 2.26147899 |
| 20 | MAP3K11 | 2.16143604 |
| 21 | ZAP70 | 2.11089825 |
| 22 | FGR | 1.98716401 |
| 23 | MAP3K14 | 1.90409411 |
| 24 | PRKAA2 | 1.89937145 |
| 25 | BTK | 1.83444196 |
| 26 | SYK | 1.74863267 |
| 27 | CDK9 | 1.74547737 |
| 28 | PDK2 | 1.70228051 |
| 29 | TBK1 | 1.68283835 |
| 30 | INSRR | 1.58892190 |
| 31 | EPHB2 | 1.57948424 |
| 32 | FGFR3 | 1.52641047 |
| 33 | LYN | 1.49240377 |
| 34 | FGFR2 | 1.43095861 |
| 35 | BMPR2 | 1.39674263 |
| 36 | HCK | 1.39304747 |
| 37 | PIK3CA | 1.34604842 |
| 38 | MYLK | 1.32435933 |
| 39 | IKBKB | 1.27590891 |
| 40 | IKBKE | 1.27134178 |
| 41 | CDK6 | 1.23495718 |
| 42 | TESK2 | 1.23428091 |
| 43 | MAP3K1 | 1.22577256 |
| 44 | FRK | 1.20535555 |
| 45 | SIK3 | 1.20038291 |
| 46 | KIT | 1.15476778 |
| 47 | TXK | 1.15360591 |
| 48 | MAP2K1 | 1.11170390 |
| 49 | PDGFRA | 1.09027834 |
| 50 | MATK | 1.07901600 |
| 51 | MARK3 | 1.07392151 |
| 52 | IRAK3 | 1.07257228 |
| 53 | GRK7 | 1.04777369 |
| 54 | MAP3K5 | 1.04232396 |
| 55 | MAP3K13 | 1.02430620 |
| 56 | ITK | 0.99352218 |
| 57 | CDK19 | 0.99218160 |
| 58 | MET | 0.98879341 |
| 59 | JAK1 | 0.98342508 |
| 60 | TGFBR2 | 0.98328047 |
| 61 | PRKD3 | 0.97503694 |
| 62 | DDR2 | 0.94079636 |
| 63 | LCK | 0.92975044 |
| 64 | PRKAA1 | 0.92531264 |
| 65 | MAP3K6 | 0.91961566 |
| 66 | TIE1 | 0.83972920 |
| 67 | LATS1 | 0.83439780 |
| 68 | YES1 | 0.81417011 |
| 69 | PHKG1 | 0.81261063 |
| 70 | PHKG2 | 0.81261063 |
| 71 | FGFR4 | 0.81191485 |
| 72 | PKN2 | 0.80779355 |
| 73 | KSR2 | 0.80507486 |
| 74 | MAP2K3 | 0.79059862 |
| 75 | JAK2 | 0.79026737 |
| 76 | MOS | 0.78354292 |
| 77 | MARK2 | 0.76022937 |
| 78 | MAP2K6 | 0.73968197 |
| 79 | FER | 0.73886585 |
| 80 | NME2 | 0.73330635 |
| 81 | CAMK1 | 0.72519039 |
| 82 | TTN | 0.69492689 |
| 83 | SIK2 | 0.68570570 |
| 84 | NEK9 | 0.68544829 |
| 85 | PDPK1 | 0.68314312 |
| 86 | PRKCH | 0.67270972 |
| 87 | IGF1R | 0.66477259 |
| 88 | JAK3 | 0.65672000 |
| 89 | EIF2AK2 | 0.64513913 |
| 90 | ILK | 0.63567079 |
| 91 | PRKACG | 0.61548344 |
| 92 | GSK3A | 0.60972342 |
| 93 | CAMKK2 | 0.60678179 |
| 94 | PTK2B | 0.59729895 |
| 95 | STK10 | 0.58154754 |
| 96 | RPS6KL1 | 0.57736761 |
| 97 | RPS6KC1 | 0.57736761 |
| 98 | MAPK7 | 0.55033442 |
| 99 | FYN | 0.53911721 |
| 100 | PAK2 | 0.53776057 |
| 101 | LATS2 | 0.53161326 |
| 102 | RET | 0.52274131 |
| 103 | MAPK11 | 0.51933119 |
| 104 | PIM1 | 0.51234067 |
| 105 | PDK1 | 0.51179656 |
| 106 | PDGFRB | 0.51141359 |
| 107 | TNK2 | 0.48808688 |
| 108 | FGFR1 | 0.47471981 |
| 109 | RPS6KA6 | 0.47467371 |
| 110 | PINK1 | 0.47244851 |
| 111 | CDK4 | 0.45806606 |
| 112 | MTOR | 0.45425177 |
| 113 | HIPK2 | 0.44157175 |
| 114 | INSR | 0.44132814 |
| 115 | CLK1 | 0.43597063 |
| 116 | TEC | 0.42630411 |
| 117 | TAOK3 | 0.42325063 |
| 118 | IRAK1 | 0.41602689 |
| 119 | FLT3 | 0.41361567 |
| 120 | BMX | 0.40842262 |
| 121 | MAPKAPK2 | 0.40478206 |
| 122 | IRAK2 | 0.40271649 |
| 123 | PRKD1 | 0.39797789 |
| 124 | CDC42BPA | 0.39168175 |
| 125 | PRKG2 | 0.38105143 |
| 126 | MAP3K3 | 0.37150656 |
| 127 | PRKD2 | 0.36474942 |
| 128 | PRKCD | 0.36234513 |
| 129 | RPS6KB1 | 0.34977665 |
| 130 | CSK | 0.34956310 |
| 131 | MAPK12 | 0.34335334 |
| 132 | DAPK2 | 0.33421207 |
| 133 | ABL2 | 0.33062307 |
| 134 | SRC | 0.32613362 |
| 135 | EPHB1 | 0.29428757 |
| 136 | PTK6 | 0.28714208 |
| 137 | CSF1R | 0.28561352 |
| 138 | MAP2K4 | 0.27111377 |
| 139 | PIK3CG | 0.26740776 |
| 140 | MAP3K8 | 0.26314413 |
| 141 | PRKCQ | 0.25632054 |
| 142 | STK11 | 0.24931952 |
| 143 | CHUK | 0.23553876 |
| 144 | RPS6KA2 | 0.23494575 |
| 145 | TAOK2 | 0.23361660 |
| 146 | ABL1 | 0.22786748 |
| 147 | ALK | 0.22630559 |
| 148 | AKT1 | 0.20177148 |
| 149 | LRRK2 | 0.19440869 |
| 150 | EPHA3 | 0.19376608 |
| 151 | TRPM7 | 0.18519794 |
| 152 | NLK | 0.15376895 |
| 153 | MAPK4 | 0.13345258 |
| 154 | MAPK3 | 0.13273474 |
| 155 | TYK2 | 0.12425195 |
| 156 | PRKACA | 0.12123516 |
| 157 | PRKCZ | 0.12020274 |
| 158 | STK3 | 0.10873663 |
| 159 | DAPK3 | 0.10535855 |
| 160 | MAPKAPK3 | 0.10461298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.41454279 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.84644076 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.67086744 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.58112103 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.97934664 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.59753557 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.43629947 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.37760118 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.16574339 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.10398806 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05893167 |
| 12 | Asthma_Homo sapiens_hsa05310 | 3.02851530 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92838206 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.54313494 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46469198 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.37257433 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.37005960 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.17241874 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.15357197 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.12749969 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10963555 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09401313 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 2.06181475 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.94783457 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87271670 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.85158591 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84801106 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81083571 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79308353 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78876695 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76724234 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71387476 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.70682205 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69322760 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67306727 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63883942 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61424603 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.60939293 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54812800 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51800240 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.51643707 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47910310 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47768884 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45165704 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42744416 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35982890 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.34814997 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34373873 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32815049 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30782567 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29929683 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27294073 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25768981 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22323213 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 1.21898073 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21615293 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20645603 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13887433 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.13634223 |
| 60 | Measles_Homo sapiens_hsa05162 | 1.09466624 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08780819 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08313222 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05033766 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03236600 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02971867 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99581829 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97869897 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96824866 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96031953 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94069349 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92772999 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91572663 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91533607 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.91329015 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89557485 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.89328821 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86497282 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84268146 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84247113 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82499414 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81945692 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79682375 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79232108 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77619418 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76818686 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76287469 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76043530 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75134562 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72998922 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70631375 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70609025 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.70497694 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.70270484 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65016893 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65008194 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64823351 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64713062 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64150609 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64107951 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63579278 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60856346 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60693103 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56628120 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.55774484 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55043851 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52174222 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.51094766 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50570044 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48488404 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46548879 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45484405 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45434791 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42385217 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.41589781 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41130803 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40969680 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40864605 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39899265 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39552918 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39382399 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38045220 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37972613 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37263419 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36067830 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35446484 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34316434 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31837905 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30056866 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29136365 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28163415 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27544644 |
| 132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27537196 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27308895 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27024162 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26029500 |
| 136 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25149943 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.24071129 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23674025 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23190567 |
| 140 | Lysosome_Homo sapiens_hsa04142 | 0.22832801 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21292761 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20612031 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19092806 |
| 144 | Lysine degradation_Homo sapiens_hsa00310 | 0.18979476 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17909274 |
| 146 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.17865060 |
| 147 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17829636 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17574880 |
| 149 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.17292141 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17260313 |
| 151 | Melanoma_Homo sapiens_hsa05218 | 0.15359190 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.13523635 |
| 153 | Salivary secretion_Homo sapiens_hsa04970 | 0.13483963 |
| 154 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13403393 |
| 155 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.12508402 |
| 156 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.12236063 |
| 157 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.11123656 |
| 158 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10931289 |
| 159 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.08653296 |
| 160 | Pertussis_Homo sapiens_hsa05133 | 0.07494524 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.07291360 |
| 162 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07066762 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04999951 |
| 164 | Viral myocarditis_Homo sapiens_hsa05416 | 0.03582883 |
| 165 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03182237 |
| 166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.02383419 |
| 167 | Platelet activation_Homo sapiens_hsa04611 | 0.02292393 |
| 168 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.01968252 |
| 169 | Prion diseases_Homo sapiens_hsa05020 | 0.01717424 |
| 170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01680597 |
| 171 | Malaria_Homo sapiens_hsa05144 | 0.00194711 |
| 172 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.00161026 |

